New studies indicate that aspirin reduces the risk of breast cancer, which is a very common disease among women. Researchers say studies conducted on about 3,000 women in New York show that the incidence of breast cancer is lower among women who regularly used aspirin. Researchers also state that the reduced risk of cancer has been found in glands stimulated by estrogen or sex hormones. They suggest that aspirin appears to inhibit the production of estrogen in the breast; however, these findings do not mean that women should start using aspirin regularly, as further research on its side effects is still needed. In the United States, one in eight women is diagnosed with breast cancer. This research was conducted in New York by Columbia University.
Aspirin Reduces the Risk of Breast Cancer Among Women
New research suggests that regular aspirin use may lower breast cancer risk among women, based on a study of 3,000 women in New York. While the findings are promising, experts caution against regular aspirin use until more research on side effects is conducted.
👥 Key Players
📰 What Happened
New research indicates that regular aspirin use may lower the risk of breast cancer among women, based on a study of 3,000 women in New York. However, experts caution against starting regular aspirin use without further research on potential side effects.
- The study involved approximately 3,000 women in New York.
- One in eight women in the U.S. is diagnosed with breast cancer.
💡 Why It Matters
📚 Background
Breast cancer is one of the most common cancers among women worldwide, and ongoing research seeks to find effective prevention methods. Aspirin is widely used for pain relief and has been studied for various health benefits.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 85%